Companies offering direct-to-consumer genomic information face tough questions about who regulates them, where they fit in health care and how to value their services. What will it take to move them from niche services to a broader customer base? Jeffrey Fox reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Stefansson, H. et al. Nature 455, 232–236 (2008).
Burrill & Company and ChangeWave Research. Personalized Medicine and Wellness Survey <http://www.burrillandco.com/content/CWSurvey_61708.pdf> (2008).
Bodmer, W. & Bonilla, C. Nat. Genet. 40, 695–701 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. What price personal genome exploration?. Nat Biotechnol 26, 1105–1108 (2008). https://doi.org/10.1038/nbt1008-1105
Issue Date:
DOI: https://doi.org/10.1038/nbt1008-1105
This article is cited by
-
Only Connect
Molecular Diagnosis & Therapy (2010)
-
Personal genomics services: whose genomes?
European Journal of Human Genetics (2009)